Michael Auguet

Title: Michael Auguet: Innovator in Cholinergic Neurotoxin Research

Introduction

Michael Auguet is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of neurotoxin research, particularly through his innovative methods for quantifying cholinergic neurotoxins. His work is essential for understanding the kinetics of action of these neurotoxins and their implications in various biological contexts.

Latest Patents

Michael Auguet holds a patent for a method that quantifies a cholinergic neurotoxin in a sample. This invention relates to determining the kinetics of action of a cholinergic neurotoxin, as well as measuring the quantity of neurotoxin present in a sample. His patent is a valuable asset in the field of toxicology and pharmacology.

Career Highlights

Michael Auguet is currently employed at Ipsen Pharma S.A.S., where he continues to advance his research and development efforts. His work at Ipsen Pharma has allowed him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.

Collaborations

Michael has worked alongside notable colleagues such as José-Antonio Camara-Ferrer and Pierre-Etienne Chabrier De Lassauniere. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Michael Auguet is a distinguished inventor whose work in cholinergic neurotoxin research has made a significant impact in the scientific community. His innovative methods and collaborations continue to pave the way for advancements in understanding neurotoxins and their effects.